First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers

Inclusion Criteria:

1. Healthy male or female 18 to ≤ 55 years old at the time of consent.

2. Healthy on the basis of physical examination, medical history, vital signs,laboratory values and 12-lead ECG performed at Screening. The participant may beincluded only if the investigator judges any abnormalities or deviations from normalto be not clinically significant.

Exclusion Criteria:

1. Prior or ongoing medical conditions, medical history, physical findings, orlaboratory abnormality that, in the Investigator's (or delegate's) opinion, mayrequire treatment or render the participant unlikely to fully complete the study, orany condition that presents undue risk from the IP or procedures or interfere withstudy assessments.

2. Have received any IP within 30 days or 5 half-lives prior to Screening (4 months ifthe previous drug was a new chemical entity), whichever is longer.